"."

During the past decade, Azienda Ospedaliero - Universitaria di Parma conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 44 clinical trials were completed, i.e. on average, 37.6% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 28 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliero - Universitaria di Parma" #1 sponsor was "Azienda Ospedaliero-Universitaria di Parma" with 13 trials, followed by "Hoffmann-La Roche" with 11 trials sponsored, "Gilead Sciences" with 10 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 8 trials sponsored and "Bayer" with 8 trials sponsored. Other sponsors include 136 different institutions and companies that sponsored additional 89 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliero - Universitaria di Parma" #1 collaborator was "AstraZeneca" with 4 trials as a collaborator, "Azienda Ospedaliero-Universitaria di Parma" with 3 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator, "University of Padova" with 3 trials as a collaborator and "Azienda Policlinico Umberto I" with 2 trials as a collaborator. Other collaborators include 87 different institutions and companies that were collaborators in the rest 87 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero - Universitaria di Parma" are "Breast Cancer" (8 trials), "Carcinoma, Non-Small-Cell Lung" (8 trials), "Coronary Artery Disease" (5 trials), "Non-Small Cell Lung Cancer" (5 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Azienda Ospedaliero - Universitaria di Parma" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero - Universitaria di Parma" are "Drug" (136 trials), "Other" (21 trials), "Procedure" (15 trials), "Device" (13 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Carboplatin" (8 trials), "Cisplatin" (6 trials), "cisplatin" (6 trials) and "radiation therapy" (6 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero - Universitaria di Parma" are 177 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Azienda Ospedaliero - Universitaria di Parma". undefined are not yet recruiting, 35 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 83 completed trials in Azienda Ospedaliero - Universitaria di Parma, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero - Universitaria di Parma, 7 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 96 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 14 trials that are defined as “Not Applicable".

Azienda Ospedaliero - Universitaria di Parma has several departments that took part in Clinical trials: "A.O.U. di Parma; SC Neurologia, Amb. Sclerosi Multipla (malattie demielinizzanti)" - 3 trials, "Ospedale Regionale Di Parma; Divisione Di Oncologia Medica" - 29 trials, "University of Parma - UO Nefrologia AOU" - 2 trials, "Az. Osp. Uni Ria Di Parma; Gastro-Enterology" - 2 trials